Apotex Acquires US Rights to Wakefulness Drugs Provigil and Nuvigil

Summary: Canadian pharmaceutical company Apotex Inc has acquired the US rights to Provigil (modafinil) and Nuvigil (armodafinil) through its affiliate, Nuvo Pharmaceuticals (Ireland). These medications, used to improve wakefulness in patients with narcolepsy, obstructive sleep apnea, or shift work sleep disorder, mark a strategic move to grow Apotex’s US specialty business. The acquisition aligns with…

Read More

Peerbridge, Maker of Monitor for OSA and Heart Conditions, to

Summary: Peerbridge Health has launched the COR-INSIGHT trial to validate the diagnostic capabilities of its Peerbridge Cor ambulatory ECG wearables, which leverage two AI-enabled SaMD platforms—CardioMIND for cardiovascular and sleep disorder indications and CardioQSync for cardiopulmonary and hemodynamic monitoring. The trial aims to provide a non-invasive, cost-effective alternative for over 30 diagnostic indications in hospital…

Read More

Goertek Reveals Smart Ring Reference Designs with Voice and Gesture Controls

Summary: At CES 2025, Goertek unveiled its Comma 2 series, a next-generation smart ring reference design that integrates advanced health monitoring and multimodal interaction capabilities. The reference designs include the Comma 2 Touch and Comma 2 Listener, featuring technologies like PPG sensors for health tracking, gesture recognition, voice commands, and device control for AR glasses…

Read More

Aircraft Noise May Raise Heart Risks, with Sleep Disruption Playing

Summary: A study led by University College London found that living near airports and being exposed to high levels of aircraft noise—especially at night—may increase the risk of heart issues, including heart attacks, strokes, and life-threatening arrhythmias. Researchers observed that individuals exposed to higher noise levels had stiffer, thicker heart muscles and reduced heart function.…

Read More

Sleep Aids May Disrupt Brain’s Nightly Waste Removal Process

Summary: A new study published in Cell reveals that norepinephrine waves during deep sleep play a critical role in the brain’s glymphatic system, which clears waste and toxic proteins linked to neurological disorders. Researchers found that sleep aids like zolpidem reduce norepinephrine waves by 50%, decreasing the brain’s fluid transport by over 30%, which may…

Read More

Eyesafe’s Blue Light Filtering Screen Protectors Improve Sleep in Validation Study

Summary: A SleepScore Labs validation study examined Eyesafe CPF70 and CPF60 blue light filtering screen protectors for their impact on sleep and eye strain. The CPF70 protector demonstrated measurable improvements in sleep quality, including enhancements in deep sleep, and participants reported a 50% reduction in eye strain severity. In contrast, CPF60 did not show measurable…

Read More